Summary
Updated Aug 31, 2026
Jonathan C. Javitt is Chairman and Chief Scientist of NRX Pharmaceuticals, Inc. (NRXP). 2 SEC Form 4 filings on record going back to 2024, most recently on 9 April 2025. Most recent open-market trade: bought $47K of NRXP on 18 December 2024. Lifetime open-market purchases: $47K.
Recent Transactions
1Every recent SEC Form 4 transaction Jonathan C. Javitt has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Jonathan C. Javitt go back to 2024: 2 primary Form 4 filings, an average of 0.7 per year. The typical open-market purchase is $47K (1 buy totaling $47K). The largest single buy on record is $47K of NRXP in 2024. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Sector
No other insider has filed at Jonathan C. Javitt's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- A/S Genmab - $234.86M of MRUS open-market activity in the last 12 months
- Weiss Asset Management LP - $233.35M of AVDL open-market activity in the last 12 months
- James Edgemond - $201.52M of UTHR open-market activity in the last 12 months
- Scilex Holding Co - $200.00M of SMNR open-market activity in the last 12 months
- Michael Benkowitz - $199.02M of UTHR open-market activity in the last 12 months
- John Oyler - $198.67M of ONC open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Jonathan C. Javitt?
Jonathan C. Javitt is a corporate insider, tracked as Chairman and Chief Scientist of NRX Pharmaceuticals, Inc. (NRXP). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Jonathan C. Javitt last file a Form 4?
The most recent primary Form 4 on record is dated 9 April 2025, one of 2 filings going back to 2024.
Has Jonathan C. Javitt been buying or selling stock?
Recorded transactions: 1 open-market purchase ($47K) and 0 open-market sales across all tracked filings.
Where can I see all of Jonathan C. Javitt's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Jonathan C. Javitt and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial